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BACKGROUND: Erectile dysfunction; the persistent inability to attain and maintain an erection sufficient to 
permit satisfactory sexual performance has been reported to be a problem in hypertensive and physically inactive 
individuals. Physical inability has been implicated in the etiology of vasculogenic erectile dysfunction and 
hypertension. The objective of this study was therefore to determine the effect of physical training on C-reactive 
protein and erectile function index in the management of erectile dysfunction in male subjects with hypertension. 
METHODS: Sixty five male subjects with hypertension were age matched and grouped into continuous, interval 
and control groups. Subjects in the interval group involved in interval training (60-79% maximum heart rate; the 
continuous group involved in continuous training (35-59% HR max) for 8 weeks for duration of 45 - 60 minutes, 
while control group remain sedentary during this period. Serum C-reactive protein was assessed and the 
International Index of Erectile Function questionnaire was used in data collection. ANOVA, Bonferroni post hoc 
analysis and Spearman correlation test was used in data analysis.  
RESULTS: The 65 age matched subjects were grouped into continuous (n=22; 61.78±7.79 years), interval (n=22; 
62.11 ± 9.32 years) and control (n=21; 64.00± 8.53 years) groups. Findings of the study revealed a significant effect 
of exercise training on C-reactive protein, erectile function index,  SBP, DBP and VO2 max of subjects with 
hypertension at p<0.05. 
CONCLUSIONS: This study revealed that the down regulatory effect of exercise training on C-reactive protein, 
SBP, DBP and VO2 max may be the likely cause for improved erectile function in subjects with hypertension and 
erectile dysfunction.  We recommend that therapeutic exercise should form part of the management modalities in 
hypertension and erectile dysfunction.  




Erectile dysfunction (ED) is a common problem, 
affecting more than half of all men between the ages of 
40 and 70 years (1, 2, 3). ED has been defined by the 
National Institutes of Health Consensus Panel on 
Impotence as the persistent inability to attain and 
maintain an erection sufficient to permit satisfactory 
sexual performance (4). 
Numerous studies have shown that ED shares several 
modifiable risk factors with cardiovascular disease 
including atherosclerosis, hypertension, hyperlipidemia, 
diabetes mellitus, smoking, obesity and sedentary 
lifestyle (5-8). Data from several studies involving 
patients with cardiac disease have shown a high 
prevalence of ED (42–75%) (9-11). According to 
Feldman et al the most common etiology for organic ED 
is vasculogenic (12). Men with hypertension have a 15% 
probability of developing complete ED (increasing to 
20% if they smoke). 
Nitric Oxide (NO) released in response to sexual 
stimulation relaxes penile vascular smooth muscle by 
increasing the intracellular cyclic guanosine 
monophosphate (cGMP) concentration. Vasodilatation of 
erectile tissues allows the sinusoidal spaces to fill with 
blood, resulting in the attainment and maintenance of an 
erection (13). Higher levels of C-reactive protein (CRP) 
might increase blood pressure by reducing NO 
production in endothelial cells (14), resulting in 
vasoconstriction and increased production of endothelin-
1 (15). 
The influence and significance of lifestyle factors in 
erectile dysfunction (ED) have been demonstrated in 
cross-sectional and prospective, randomized, controlled 
trials. A review of several recent epidemiologic studies in 
several countries have shown that modifiable lifestyle or 
risk factors, including physical activity in particular, are 
directly related to the occurrence of ED (16)., 
Furthermore, the role of lifestyle changes (weight loss, 
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physical activity) demonstrated to be effective in 
modifying ED in moderately obese, sedentary men. 
It is a well established fact that sedentary lifestyle 
contributes to increased risk of cardiovascular diseases 
especially hypertension. Studies have shown that exercise 
training lowers blood pressure in hypertensive patients 
(17-20).  The value of risk factor modification and 
lifestyle change in the clinical management of ED and 
concomitant cardiovascular illness was documented in 
other studies (16). However; few studies have actually 
investigated the effect of physical training in the 
management of ED. The objective of the present study 
was therefore to assess the therapeutic efficacy of 
exercise in the management of ED in hypertensive 
patients.  
Subjects and Methods 
Age matched randomized double blind independent 
groups design was used to determine the influence of the 
interval and continuous training program on 
cardiovascular parameters.  Subjects’ age were arranged 
in ascending order (50 to 70 years) and then assigned to 
interval, continuous and control groups in an alternating 
pattern (age matched). One week wash out period was 
established and pretest was administered to all subjects 
on the last day of the wash out period. Following wash 
out and pretest assessment, all subjects were placed on 
methyl-dopa (aldomet), the interval and continuous 
groups involved in interval and continuous training 
programs for 8 weeks, while the control group remained 
sedentary during this period. And at the end of the 
training and sedentary period, another one week wash out 
period was established and posttest was administered to 
all subjects on the last day of the wash out period.  
Population for the study was male subjects with 
essential hypertension attending the hypertensive clinic 
of Murtala Mohammed Specialist Hospital (MMSH), 
Kano, Nigeria. Those complaining of ED were referred 
to a specialized clinic. The diagnosis of ED was 
established using the international index of erectile 
function (IIEF [figure 1]) (21) and all men were 
questioned about previous ED treatment. The study was 
conducted from July to November 2007. Seventy five 
hypertensive subjects with ED were assigned to 3 groups; 
interval (n=25), continuous (n=25) and control (n=25) 
groups. Ethical approval for the study was granted by the 
Ethical Committee of Kano State Hospitals Management 
Board. Subject were fully informed about the 
experimental procedures, risk and protocol, after which 
they gave their informed consent. 
Inclusion criteria: Only those diagnosed with ED of 
vasculogenic origin and who volunteered to participate in 
the study were recruited. Subjects with chronic and stable 
(> 1 year duration) hypertension (SBP between 140-179 
& DBP between 90-109 mmHg) were selected. Only 
those who had stopped taking antihypertensive drugs or 
on a single antihypertensive medication, non 
psychological/psychiatry disorder were recruited (17).  
Exclusion criteria: Obese or underweight (Body max 
index [BMI] > 30 & < 20 kg/m
2 
respectively), smokers, 
alcoholic, diabetic (Fasting blood sugar [FBS] > 
6.40mmol/L), other cardiac, renal, respiratory disease, 
benign prostatic hypertrophy, liver failure, low 
testosterone level, neurologic disorder patients were 
excluded. Those involved in vigorous physical activities 
and above averagely physically fit (VO2max >27 & >33 
ml/kg.min for over 60 & 50 years old respectively) were 
also excluded. 
Pretest procedure 
All subjects on antihypertensive drugs were asked 
to stop all forms of medication and given placebo tablets 
(consisted of mainly lactose and inert substance) in a 
single blind method (22). All subjects including those 
who were not on any antihypertensive medications were 
placed on placebo tablets for one week (7 days); this is 
known as “Wash out period”. The purpose of the wash 
out period was to get rid of the effects of previously 
taken antihypertensive drugs/medications. During the 
wash out period all subjects were instructed to report to 
the hypertensive clinic for daily blood pressure 
monitoring and general observation. The pretest 
procedure was conducted at the last day of the wash out 
period in the Department of Physiotherapy of Murtala 
Mohammed Specialist Hospital (MMSH), Kano 8:00 - 
10:00 am. 
Subjects resting SBP and DBP were monitored 
from the right arm using an automated digital electronic 
BP monitor (Omron digital BP monitor, Model 11 EM 
403c; Tokyo Japan). The measurements were taken 
between 8:00 - 10:00 am on each test day.  
Pre and post treatment venous blood samples were 
obtained between 8: 00 am and 10:00 pm after about 12 
hour overnight fast. Serum samples were transferred in to 
plastic containers, sealed and labeled. All samples were 
stored in a refrigerator at -80
0
C until analysis (23).   The 
high sensitive C-reactive protein was determined 
qualitatively and semi-quantitatively using commercial 
latex agglutination method (Latex liquid reagents and 
manual by Dialab Producktion und Vertrieb Von 
Chemisch, Gesellschatt M.B.H).  A titer (highest dilution 
showing positive result or lowest detection point) is then 
established at 0.2mg/l (values lower than 0.2 was 
regarded as 0.1mg/l).    
Erectile function was assessed
 
by completing 
questions 1 to 5 on the International Index of
 
Erectile 
Function (IIEF), which is a multidimensional 
questionnaire (21).
 
The IIEF score represents
 
the sum of 
questions 1 to 5, with a maximum score of 25; a score
 
of 
21 or less indicates erectile dysfunction. 
Stress test: The Young Men Christian Association 
(YMCA) sub maximal cycle ergometry test protocol was 
used to assess subject’s aerobic power as described by 
American College of Sports Medicine (ACSM) (24); 
Golding et al, (25). The YMCA protocol uses two to four 
3-minutes stages of continuous exercise, two Heart rate 
(HR)-power output data points will be needed (steady 
state HR) of between 110 and 150 beat/min. 
The two steady state HR were plotted against the 
respective workload on the YMCA graph sheet. A 
straight line was drawn through the two points and 
extended to the subjects predicted maximum HR (220-




Age). The point at which the diagonal line intersects the 
horizontal predicted maximum heart rate [HR max] line 
represents the maximal working capacity for the subject. 
A perpendicular line was dropped from this point to the 
baseline where the maximal physical workload capacity 
was read in kg/min
-1
, which was used to predict the 
subjects VO2 max. This procedure was done for both pre 
and posttest stress test.  
Training program: Following stress test and prior to the 
exercise training, all subjects in continuous, interval and 
control groups were re-assessed by a physician and were 
prescribed with aldomet as necessary. Subjects 
maintained these prescriptions with regular medical 
consultation and observation through-out the period of 
training, so also the control group during the period of 
sedentary. 
The continuous group (group 1): subjects in the 
continuous group exercised on a bicycle ergometer at a 
low intensity of between 35-59% of their HR max 
reserve that was estimated 220 minutes for the age of a 
subject as recommended by ACSM (20). The starting 
workload was 100 kg (17 watts) which was increased at a 
pedal speed of 50 (revolution per minute) rpm to obtain a 
HR max 35% was increased in the first two weeks and 
level up at 59% HR max throughout the remaining part 
of the training period. The initial of exercise session was 
increased from 45 minutes in the first two weeks of 
training to level up at 60 minutes throughout the 
remaining part of the training.  
The interval group (group 2): subjects in the 
interval group exercised on a bicycle ergometer at a 
moderate exercise intensity of between 60% and 79% HR 
max at a work/rest ratio of 1:1(20). Subjects pedaled at a 
speed of 50 rpm with the initial workload of 17 watts 
which was increased to HR of between 60% and 79% HR 
max. In the first two weeks, the intensity was 60% HR 
max which was then increased and level up at 79% HR 
max thought-out the remaining period of the training. 
The exercise session was increased from 45 minutes in 
the first two weeks and maintained at 60 minutes 
throughout the remaining period of the training program. 
The frequency of training was three times per weeks. The 
interval program was for 6 minutes work intervals 
interspaced with 6 minute relief intervals in the first two 
weeks while in the last 6 weeks the interval program was 
6 minutes work. Intervals interspaced by 6 minutes relief. 
At the rest intervals, subjects pedaled at zero resistant.  
Exercise session of three times per week was 
maintained throughout the 8 weeks period of training for 
both the interval and continuous groups. 
The control group (group 3): subjects in the control 
group were instructed not to undertake any vigorous 
physical activity during the 8 weeks period of study. 
During the 8 weeks training and sedentary 
period, all subjects (interval, continuous & control) were 
placed on methyldopa according to their pre recruitment 
doses. Aldomet was preferred because it does not alter 
normal hemodynamic responses to exercise (26). It is a 
well-tolerated and mostly prescribed antihypertensive 
drug in Nigeria (27), particularly Northern Nigeria where 
the study was conducted (28). 
Posttest procedure 
At the end of the 8 weeks training period, all 
subjects were asked to stop methyldopa (Aldomet) and 
were prescribed with placebo tablets in a single blinded 
method for one week. In the last day of the post training 
wash out period, fasting blood samples were collected as 
described earlier. 
Posttest stress test: Stress test was also conducted at the 
last day of the posttest wash out period as described 
earlier. 
Post training SBP, DBP, CRP assessment and stress test 
were conducted as described earlier in the pretest 
procedures using standardized protocols, techniques and 
methods and all subjects were presented with the IIEF 
questionnaire. 
The coded responses on the IIEF were then entered 
in to computer and analyzed using the statistical package 
for the Social Science (SPSS) window version 16.0 
Chicago, IL; USA. ANOVA and Temhane post hoc 
analysis was used (in the SPSS ANOVA, data were 
entered as ordinal data for CRP, IIEF and interval for 
SBP, DBP & VO2max). The descriptive statistics 
(Means, standard deviations) of the subjects’ physical 
characteristics were analyzed. Spearman correlation was 
also performed. In ANOVA, the difference between the 
pre and posttest values (changed score) was used as the 






Sixty five subjects (22 from interval, 22 from continuous 
& 21 from control group) completed the eight weeks 
training program. Ten subjects (3 from interval, 3 from 
continuous and 4 from control group) had dropped out 
because of non-compliance, unfavorable responses to 
methyldopa and exercise training or had incomplete data; 
therefore, the data of 65 subjects were used in the 
statistical analysis. 
 The subject’s age ranged from 50 to 70years with 
mean ± SD: interval (62.11± 9.32years); continuous 
(61.78± 7.79years) and Control (64.00 ±8.53years) 
groups. There was no significant groups’ difference in 
baseline physical characteristics and fasting blood sugar 
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level (Table 1). However groups differ significantly in 
height. 
Subjects’ baseline (pre-training) and post training values 
for variables of interest were checked. ANOVA results 
indicated that groups differ significantly in CRP (F 
=18.556, p= 0.000) and IIRF (F=10.995, p=0.000). 
Bonferroni post hock indicated significant group 
differences in all variables. Figure 1 showed significant 
negative correlation between changes in CRP and IIEF 
score (r= -0.547) (Tables 2 and 3).  
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This study indicated significant reduction in SBP, DBP 
and significant increase in VO2max as a result of exercise 
training; several previous studies have reported similar 
findings (29-31). This study also indicated significant 
effect of exercise on erectile dysfunction and significant 
negative correlation between IIEF and CRP as a result of 
exercise training.  
The finding of the present study is in agreement 
with other studies (32-34), whish reported significant 
reduction in CRP value following aerobic exercise and 
inverse correlation between CRP count and VO2max in 
healthy, mild to moderate hypertensive and coronary 
heart disease patients. Several other studies of large 
population cohorts, including the British Regional Heart 
Study (35), the Third National Health and Nutrition 
Examination Survey (36, 37), the Cardiovascular Health 
Study (38), the men's Health Professionals Follow-up 
Study, the Nurses' Health Study II (39) and the Health, 
Aging and Body Composition Study (Health ABC) (40), 
provided evidence for an inverse, independent dose–
response relation between plasma CRP concentration and 
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The physiological basis for the therapeutic role of 
both continuous and interval exercise in the management 
of ED in hypertension as reported in the present study 
could be related to the biochemical, neural, and hormonal 
changes in the blood vessel walls that induce an acute 
and long-term blood vessel relaxation. The blood vessels 
may relax after each exercise session because of body 
warming effects, local production of certain chemicals, 
such as lactic acid and nitric oxide; decreases in nerve 
activity and changes in hormones and their receptors (41, 
42). Over time, as the exercise is repeated, there is 
growing evidence that a long lasting effect on blood 
vessels. Chronic (regular, long-term) physical training 
may reduce basal concentrations of inflammatory 
markers. Data from cross-sectional observational studies 
have shown an inverse association between markers of 
systemic inflammation, physical activity and fitness 
status (35-43).  
 In conclusion, the finding of this study 
demonstrated that exercise improve erectile function in 
older hypertensive men with erectile dysfunction. This 
improvement was associated with amelioration of 
endothelial function through reduction in markers (CRP) 
of systemic vascular inflammation. Though the findings 
of this study provided a rational base for recommending 
exercise in the management of erectile dysfunction, there 
are some limitations which include failure to directly 
assess endothelial function, rather CRP level was used. 
Also few number of participants. These factors warrant 
more attention in future study. 
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